Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/29/2025

Kenalog Injection Dosage and Administration

Dosing by Clinical Indication

  • For large joints, a dose of 20-40 mg per injection is recommended, and for acute crystal-induced arthritis, 60 mg intramuscular triamcinolone acetonide is suggested for monoarticular or oligoarticular attacks, according to the Annals of the Rheumatic Diseases 1
  • For alopecia areata, a 5-10 mg/mL concentration injected into affected areas is recommended, and for resistant dermatologic lesions, a 10-20 mg/mL concentration is suggested, as per Praxis Medical Insights 2
  • For pes anserine bursa, a 20-40 mg total dose, using 0.05-0.1 mL per injection site, is recommended, according to Praxis Medical Insights 2
  • Intralesional treatment for inflammatory nodulocystic acne flattens most nodules within 48-72 hours, as reported by Praxis Medical Insights 3
  • For adrenal insufficiency in pediatric patients, a dose of 2-3 mg/kg (maximum 100 mg) over 3-5 minutes, followed by maintenance dosing, is recommended, according to Pediatrics 4

Critical Safety Considerations

  • Local reactions, including skin atrophy, telangiectasia, pigmentary changes, striae, and folliculitis, can occur, as reported by Praxis Medical Insights 2, 3
  • Active infections are a contraindication at sites with impetigo or herpes, and hypersensitivity is a contraindication in patients with triamcinolone allergy, according to Praxis Medical Insights 3
  • The medication should be used with caution in patients with diabetes, heart failure, or severe hypertension, as per Praxis Medical Insights 3
  • Extensive plaque psoriasis, pustular psoriasis, or erythrodermic psoriasis are not recommended for treatment, according to Praxis Medical Insights 3

Clinical Pearls

  • Facial applications require caution due to the thinner skin and higher risk of steroid-induced atrophy, as reported by Praxis Medical Insights 2
  • Intertriginous areas should be treated sparingly to minimize atrophy risk, according to Praxis Medical Insights 2

REFERENCES

2

Management of Corticosteroid-Responsive Dermatoses [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Tricortone 0.02% Ointment Uses for Inflammatory Skin Conditions [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025